
Shangrila Intermediaries Private Limited
About Shangrila Intermediaries Private Limited
Data last updated:
Shangrila Intermediaries Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC043270.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vikram Bery and Neeraja Thippabhotla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 512 Meridian Plaza Ameerpet, Hyderabad, Telangana, India – 500016.
As per the financials filed for FY 2025, the company reported a revenue of ₹64,132, a decline of 76% compared to the previous year. For the same year it recorded a net loss of ₹67,077 (net margin -104.6%) and EBITDA of -₹57,228 (EBITDA margin -89.2%). Revenue has declined at a compounded annual rate (CAGR) of 27% over three years and 28% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Shangrila Intermediaries has one previous CIN (Corporate Identification Number): U24239AP2004PTC043270. The current CIN is U24239TG2004PTC043270, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC043270 | Current |
| U24239AP2004PTC043270 | Previous |
Contact details
Shangrila Intermediaries Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address512 Meridian Plaza Ameerpet, Hyderabad, Telangana, India – 500016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Shangrila Intermediaries Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shangrila Intermediaries is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Shangrila Intermediaries Private Limited, buy the company report.
Financials of Shangrila Intermediaries Private Limited
FY 2025 filings availableShangrila Intermediaries Private Limited reported revenue of ₹64,132 (down 76% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 28% over five years, including a 76% fall in the latest year. EBITDA fell 141% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹57,228 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹67,077 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -89.2% | ||||
| Net Profit Margin | -104.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shangrila Intermediaries Private Limited, buy the company report.
Board of directors of Shangrila Intermediaries Private Limited
Shangrila Intermediaries has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikram Bery Also directs: Apogen Remedies Private Limited, Bago Laboratories Private Limited | Additional Director | 23 Dec 2014 | 11 Years 10 Months | Current |
| Neeraja Thippabhotla | Additional Director | 20 Mar 2015 | 11 Years 7 Months | Current |
Auditor
Shangrila Intermediaries Private Limited is audited by SIRISH & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SIRISH & CO | FY 2020 | 003909S |
Shareholding
The shareholding of Shangrila Intermediaries Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Shangrila Intermediaries Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shangrila Intermediaries Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shangrila Intermediaries Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Shangrila Intermediaries Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Shangrila Intermediaries Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Lim Hwee Peow ceased to be Director on 20 Mar 2015.
Frequently asked questions
Shangrila Intermediaries is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 May 2004 (22+ years old) and is registered under CIN U24239TG2004PTC043270.
Shangrila Intermediaries has 2 current directors:
- Vikram Bery - Additional Director
- Neeraja Thippabhotla - Additional Director
The latest financial statements of Shangrila Intermediaries on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Shangrila Intermediaries is U24239TG2004PTC043270. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shangrila Intermediaries was incorporated on 18 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Lim Hwee Peow ceased to be Director on 20 Mar 2015. Neeraja Thippabhotla was appointed as Additional Director on 20 Mar 2015. Brij Lal Bery ceased to be Managing Director on 23 Dec 2014. Shangrila Intermediaries has 4 board changes on record in total.
The registered office of Shangrila Intermediaries is at 512 Meridian Plaza Ameerpet, Hyderabad, Telangana, India – 500016.
Shangrila Intermediaries operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Shangrila Intermediaries is compliant as of 19 August 2026. The company is actively filing with the Registrar of Companies.
Shangrila Intermediaries can be reached at its registered office: 512 Meridian Plaza Ameerpet, Hyderabad, Telangana, India – 500016.

